Abstract
Aim and Objective: C-Jun-N-terminal kinase -1 (JNK -1) is a seriene/threonine kinase protein and a member of mitogen activated protein family (MAP– Kinase). The activation of JNK-1 leads to cell proliferation, cell death, DNA repair and metabolism. In our study we aim in creating a novel JNK-1 inhibitor.
Material and Method: Various computational techniques like 3D-atom based QSAR analysis; pharmacophore based virtual screening; molecular docking and Density functional theory approaches are utilised to obtain novel JNK-1 inhibitor.
Result: Pharmacophores with pharmacophoric features as two hydrogen bond acceptors (A), one hydrogen bond donor (D), one hydrophobic (H) and one aromatic ring (R) are generated. Amongst the generated pharmacophore hypothesis, AADHR.6 was found to have good survival score of 3.214 and is used to derive atom based 3D – QSAR model. The obtained 3D – QSAR model has excellent squared correlation coefficient value (R2= 0.9272) and a good fisher ratio (F= 273.9). The reliability and robustness of the chosen model is validated both internally and externally to obtain good statistical results. The model AADHR.6 is used in virtual screening of Zinc and NCI databases for potential inhibitors. Resulting hit compounds from virtual screening are then subjected to docking and Density Functional Theory (DFT) studies.
Conclusion: Both docking and DFT studies brings out two lead compounds with good inhibitory activity against the receptor. Thus the work presents a novel JNK – 1 inhibitor that can serve as potential therapeutics for the treatment of various diseases associated with abnormal JNK -1 functioning.
Keywords: JNK-1, 3D-QSAR, virtual screening, docking, DFT, HOMO, LUMO.
Combinatorial Chemistry & High Throughput Screening
Title:Atom Based 3D-QSAR, Molecular Docking and Density Functional Theory Approaches to Identify Novel JNK-1 Inhibitor
Volume: 19 Issue: 9
Author(s): Ramanathan Shylaja, Rengarajan Kavitha and Chandrasekaran Meganathan
Affiliation:
Keywords: JNK-1, 3D-QSAR, virtual screening, docking, DFT, HOMO, LUMO.
Abstract: Aim and Objective: C-Jun-N-terminal kinase -1 (JNK -1) is a seriene/threonine kinase protein and a member of mitogen activated protein family (MAP– Kinase). The activation of JNK-1 leads to cell proliferation, cell death, DNA repair and metabolism. In our study we aim in creating a novel JNK-1 inhibitor.
Material and Method: Various computational techniques like 3D-atom based QSAR analysis; pharmacophore based virtual screening; molecular docking and Density functional theory approaches are utilised to obtain novel JNK-1 inhibitor.
Result: Pharmacophores with pharmacophoric features as two hydrogen bond acceptors (A), one hydrogen bond donor (D), one hydrophobic (H) and one aromatic ring (R) are generated. Amongst the generated pharmacophore hypothesis, AADHR.6 was found to have good survival score of 3.214 and is used to derive atom based 3D – QSAR model. The obtained 3D – QSAR model has excellent squared correlation coefficient value (R2= 0.9272) and a good fisher ratio (F= 273.9). The reliability and robustness of the chosen model is validated both internally and externally to obtain good statistical results. The model AADHR.6 is used in virtual screening of Zinc and NCI databases for potential inhibitors. Resulting hit compounds from virtual screening are then subjected to docking and Density Functional Theory (DFT) studies.
Conclusion: Both docking and DFT studies brings out two lead compounds with good inhibitory activity against the receptor. Thus the work presents a novel JNK – 1 inhibitor that can serve as potential therapeutics for the treatment of various diseases associated with abnormal JNK -1 functioning.
Export Options
About this article
Cite this article as:
Shylaja Ramanathan, Kavitha Rengarajan and Meganathan Chandrasekaran, Atom Based 3D-QSAR, Molecular Docking and Density Functional Theory Approaches to Identify Novel JNK-1 Inhibitor, Combinatorial Chemistry & High Throughput Screening 2016; 19 (9) . https://dx.doi.org/10.2174/1386207319666160901100406
DOI https://dx.doi.org/10.2174/1386207319666160901100406 |
Print ISSN 1386-2073 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
Call for Papers in Thematic Issues
Artificial Intelligence Methods for Biomedical, Biochemical and Bioinformatics Problems
Recently, a large number of technologies based on artificial intelligence have been developed and applied to solve a diverse range of problems in the areas of biomedical, biochemical and bioinformatics problems. By utilizing powerful computing resources and massive amounts of data, methods based on artificial intelligence can significantly improve the ...read more
Eco-friendly Agents for Biological Control of Pathogenic Diseases
The discovery of an alternative biological approach to disease management includes work on medicinal products derived from natural sources as a starting point for the development of eco-friendly agents for these diseases and the injuries they cause, as well as reducing human contact with hazardous chemicals and their residues. We ...read more
Emerging trends in diseases mechanisms, noble drug targets and therapeutic strategies: focus on immunological and inflammatory disorders
Recently infectious and inflammatory diseases have been a key concern worldwide due to tremendous morbidity and mortality world Wide. Recent, nCOVID-9 pandemic is a good example for the emerging infectious disease outbreak. The world is facing many emerging and re-emerging diseases out breaks at present however, there is huge lack ...read more
Exploring Spectral Graph Theory in Combinatorial Chemistry
Scope of the Thematic Issue: Combinatorial chemistry involves the synthesis and analysis of a large number of diverse compounds simultaneously. Traditional methods rely on brute force experimentation, which can be time-consuming and resource-intensive. Spectral Graph Theory, a branch of mathematics dealing with the properties of graphs in relation to the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting SphK1 as a New Strategy against Cancer
Current Drug Targets Sugars that Glow in the Dark: Fluorescent Tagged Glucose Bioprobes and their Facilitation of the Drug Discovery Process
Current Medicinal Chemistry Recent Advances in Drug Design of Epidermal Growth Factor Receptor Inhibitors
Current Medicinal Chemistry NF-κ B and Rheumatic Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Contextualizing the Genes Altered in Bladder Neoplasms in Pediatric and Teen Patients Allows Identifying Two Main Classes of Biological Processes Involved and New Potential Therapeutic Targets
Current Genomics Design, Synthesis and Antitumor Activity of Novel Dispiro[oxindole-cyclohexanone]- pyrrolidines
Current Pharmaceutical Design Meet Our Editorial Board Member
Anti-Cancer Agents in Medicinal Chemistry A Comprehensive Review on Nanotechnology-Based Innovations in Topical Drug Delivery for the Treatment of Skin Cancer
Current Pharmaceutical Design Percutaneous Laser Ablation of Small Hepatocellular Carcinoma
Current Medical Imaging Therapeutic Strategies to Target Multiple Kinases in Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry PLK1 Inhibition: Prospective Role for the Treatment of Pediatric Tumors
Current Drug Targets Approaching the Increasing Complexity of Non-small Cell Lung Cancer Taxonomy
Current Pharmaceutical Design Novel Inhibitors of Inosine Monophosphate Dehydrogenase in Patent Literature of the Last Decade
Recent Patents on Anti-Cancer Drug Discovery Mitochondria: A Promising Target for Anticancer Alkaloids
Current Topics in Medicinal Chemistry Cyclophilin A as a Target of Cisplatin Chemosensitizers
Current Cancer Drug Targets Therapeutic Transfer of DNA Encoding Adenoviral E1A
Recent Patents on Anti-Cancer Drug Discovery Therapeutic Potential of Targeting Glypican-3 in Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry Current Protein-based Anti-angiogenic Therapeutics
Mini-Reviews in Medicinal Chemistry Cytochrome P450 2W1 (CYP2W1) in Colorectal Cancers
Current Cancer Drug Targets Glioma Stem Cell Maintenance: The Role of the Microenvironment
Current Pharmaceutical Design